Log in to save to my catalogue

Serum biomarkers confirming stable remission in inflammatory bowel disease

Serum biomarkers confirming stable remission in inflammatory bowel disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37b17cb0522542b7b2404374a3412388

Serum biomarkers confirming stable remission in inflammatory bowel disease

About this item

Full title

Serum biomarkers confirming stable remission in inflammatory bowel disease

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-03, Vol.11 (1), p.6690-6690, Article 6690

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Crohn's disease (CD) and ulcerative colitis (UC) have a chronic-remittent course. Optimal management of inflammatory bowel diseases (IBD) relies on early intervention, treat-to-target strategies and a tight disease control. However, it is challenging to assess the risk of relapses in individual patients. We investigated blood-based biomarkers for t...

Alternative Titles

Full title

Serum biomarkers confirming stable remission in inflammatory bowel disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_37b17cb0522542b7b2404374a3412388

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37b17cb0522542b7b2404374a3412388

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-86251-w

How to access this item